Triglycerides and Cardiovascular Risk

被引：107

作者：

Harchaoui, K. E. L. ^{[1
]}

Visser, M. E. ^{[1
]}

Kastelein, J. J. P. ^{[1
]}

Stroes, E. S. ^{[1
]}

Dallinga-Thie, G. M. ^{[2
]}

机构：

[1] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands

[2] Acad Med Ctr, Lab Expt Vasc Med, G1-113,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands

来源：

CURRENT CARDIOLOGY REVIEWS | 2009年 / 5卷 / 03期

关键词：

Triglycerides; coronary heart disease; lipoproteins; lipolytic enzymes;

D O I：

10.2174/157340309788970315

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

In 1996 a meta-analysis was published showing that an increase in plasma triglyceride (TG) levels was associated with an increase in CHD risk, even after adjustment for high density lipoprotein cholesterol (HDL-C) levels. Very recently, two studies were published that further extent the early observation and showed the importance of nonfasting plasma triglyceride (TG) levels in the prediction of risk on coronary heart disease (CHD). In the current review we have summarized all available evidence obtained in clinical studies showing that treatment guidelines should reconsider to include nonfasting TG in their risk assessments as nonfasting TG levels may better predict CVD risk.

引用

页码：216 / 222

页数：7

共 57 条

[1]

Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes [J].

Abdel-Maksoud, Madiha ;

Sazonov, Vasilisa ;

Gutkin, Stephen W. ;

Hokanson, John E. .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 51 (04) :331-351

[2]

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome [J].

Adiels, Martin ;

Olofsson, Sven-Olof ;

Taskinen, Marja-Riitta ;

Boren, Jan .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (07) :1225-1236

[3]

Assmann G, 1998, EUR HEART J, V19, pA2

[4]

Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study [J].

Austin, MA ;

McKnight, B ;

Edwards, KL ;

Bradley, CM ;

McNeely, MJ ;

Psaty, BM ;

Brunzell, JD ;

Motulsky, AC .

CIRCULATION, 2000, 101 (24) :2777-2782

[5]

Incidence of coronary heart disease in type 2 diabetic men and women - Impact of microvascular complications, treatment, and geographic location [J].

Avogaro, Angelo ;

Giorda, Carlo ;

Maggini, Marina ;

Mannucci, Edoardo ;

Raschetti, Roberto ;

Lombardo, Flavia ;

Spila-Alegiani, Stefania ;

Turco, Salvatore ;

Velussi, Mario ;

Ferrannini, Ele .

DIABETES CARE, 2007, 30 (05) :1241-1247

[6]

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women [J].

Bansal, Sandeep ;

Buring, Julie E. ;

Rifai, Nader ;

Mora, Samia ;

Sacks, Frank M. ;

Ridker, Paul M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (03) :309-316

[7]

Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB [J].

Blasiole, Daniel A. ;

Oler, Angie T. ;

Attie, Alan D. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (17) :11374-11381

[8]

Lipoprotein management in patients with cardiometabolic risk - Consensus conference report from the American diabetes association and the American college of cardiology foundation [J].

Brunzell, John D. ;

Davidson, Michael ;

Furberg, Curt D. ;

Goldberg, Ronald B. ;

Howard, Barbara V. ;

Stein, James H. ;

Witztum, Joseph L. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (15) :1512-1524

[9]

Lipoprotein management in patients with cardiometabolic risk [J].

Brunzell, John D. ;

Davidson, Michael ;

Furberg, Curt D. ;

Goldberg, Ronald B. ;

Howard, Barbara V. ;

Stein, James H. ;

Witztum, Joseph L. .

DIABETES CARE, 2008, 31 (04) :811-822

[10]

Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins [J].

Dallinga-Thie, Geesje M. ;

Dullaart, Robin P. F. ;

van Tol, Arie .

CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (03) :251-257

← 1 2 3 4 5 6 →